{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:05:39Z","timestamp":1791363939384,"version":"4.3.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":644,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000064"],"award-info":[{"award-number":["82000064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1913210"],"award-info":[{"award-number":["U1913210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000064"],"award-info":[{"award-number":["82000064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1913210"],"award-info":[{"award-number":["U1913210"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We aimed to evaluate the effects of radiofrequency catheter ablation (RFCA) and the factors influencing mortality after RFCA in patients with pulmonary hypertension (PH) and atrial flutter (AFL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Fifty-eight consecutive PH patients with AFL who underwent an electrophysiological study and RFCA between April 2013 and August 2021 were selected for this study. In the study population, pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) was the most common type of PH (n = 34, 59%), followed by idiopathic pulmonary arterial hypertension (IPAH) (n = 19, 33%). Typical atrial flutter was the most common type of atrial flutter (n = 50, 86.2%). Sinus rhythm was restored in 53 (91.4%) patients during RFCA. After a mean follow-up of 33.8 months, AFL recurred in a total of 22 patients. Nine of them underwent repeat RFCA, and the site of the repeat ablation was not exactly the same as the first. At a median follow-up of 34.6 months after the last ablation, none of the patients who underwent repeat RFCA experienced AFL recurrence, and all of these patients survived. There were no procedure-related complications during hospitalization or follow-up. Univariate Cox regression analysis suggested that AFL recurrence after the last ablation was not associated with all-cause mortality. NT-proBNP (HR: 1.00024, 95% CI: 1.00008\u20131.00041, P = 0.004), pulmonary artery systolic pressure (PASP) (HR: 1.048, 95% CI: 1.020\u20131.076, P = 0.001), and IPAH (vs. PAH-CHD, HR: 7.720, 95% CI: 1.437\u201341.483, P = 0.017) were independent predictors of all-cause mortality in PH patients with AFL after RFCA. Receiver operating characteristic (ROC) curve analysis revealed that the area under the curve (AUC) of PASP for predicting all-cause mortality was 0.708. There was no significant difference in the Kaplan\u2013Meier curves for all-cause mortality between patients with AFL recurrence after the last ablation and those without recurrence (P = 0.851). Patients with higher PASP (\u2265110 mmHg) and IPAH showed the lower survival rate in Kaplan\u2013Meier curves.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Repeat ablation was safe and feasible in patients with recurrent AFL and can maintain sinus rhythm. AFL recurrence was not associated with all-cause mortality, and patients with high PASP or IPAH were at higher risk for adverse outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.14659","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T23:09:17Z","timestamp":1704928157000},"page":"883-892","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Radiofrequency Catheter Ablation for Pulmonary Hypertension Patients with Atrial Flutter"],"prefix":"10.1093","volume":"11","author":[{"given":"Aikai","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongda","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijie","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Cardiovascular Institute, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"key":"2026012113160862700_ehf214659-bib-0001","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","article-title":"2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"43","author":"Humbert","year":"2022","journal-title":"Eur Heart J"},{"key":"2026012113160862700_ehf214659-bib-0002","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078132","article-title":"Risk factors for hemoptysis in idiopathic and hereditary pulmonary arterial hypertension","volume":"8","author":"Tio","year":"2013","journal-title":"PLoS ONE"},{"key":"2026012113160862700_ehf214659-bib-0003","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.amjcard.2018.10.028","article-title":"Frequency, predictors, and prognostic impact of pulmonary artery aneurysms in patients with pulmonary arterial hypertension","volume":"123","author":"Nuche","year":"2019","journal-title":"Am J Cardiol"},{"key":"2026012113160862700_ehf214659-bib-0004","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1002\/clc.23803","article-title":"The spectrum and prevalence of arrhythmia in different clinical pulmonary hypertension groups in Chinese population","volume":"45","author":"Xue","year":"2022","journal-title":"Clin Cardiol"},{"key":"2026012113160862700_ehf214659-bib-0005","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245752","article-title":"The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension","volume":"16","author":"Fingrova","year":"2021","journal-title":"PLoS ONE"},{"key":"2026012113160862700_ehf214659-bib-0006","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ijcard.2010.09.065","article-title":"Clinical implications of supraventricular arrhythmias in patients with severe pulmonary arterial hypertension","volume":"146","author":"Ruiz-Cano","year":"2011","journal-title":"Int J Cardiol"},{"key":"2026012113160862700_ehf214659-bib-0007","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.amjcard.2014.07.079","article-title":"Frequency of supraventricular arrhythmias in patients with idiopathic pulmonary arterial hypertension","volume":"114","author":"Wen","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026012113160862700_ehf214659-bib-0008","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.hlc.2012.06.005","article-title":"Ablation of typical right atrial flutter in patients with pulmonary hypertension","volume":"21","author":"Luesebrink","year":"2012","journal-title":"Heart Lung Circ"},{"key":"2026012113160862700_ehf214659-bib-0009","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.hlc.2015.10.008","article-title":"The management of supraventricular tachyarrhythmias in patients with pulmonary arterial hypertension","volume":"25","author":"Malaczynska-Rajpold","year":"2016","journal-title":"Heart Lung Circ"},{"key":"2026012113160862700_ehf214659-bib-0010","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.ijcard.2022.09.031","article-title":"Atrial flutter and fibrillation in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension in the ASPIRE registry: comparison of rate versus rhythm control approaches","volume":"371","author":"Sammut","year":"2023","journal-title":"Int J Cardiol"},{"key":"2026012113160862700_ehf214659-bib-0011","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/j.1540-8167.2012.02387.x","article-title":"Catheter ablation of typical atrial flutter in severe pulmonary hypertension","volume":"23","author":"Bradfield","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026012113160862700_ehf214659-bib-0012","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95508-3","article-title":"Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia","volume":"11","author":"Kamada","year":"2021","journal-title":"Sci Rep"},{"key":"2026012113160862700_ehf214659-bib-0013","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad131","article-title":"Catheter ablation of atrial fibrillation and atrial tachycardia in patients with pulmonary hypertension: a randomized study","volume":"25","author":"Havranek","year":"2023","journal-title":"Europace"},{"key":"2026012113160862700_ehf214659-bib-0014","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.674909","article-title":"Radiofrequency catheter ablation of supraventricular tachycardia in patients with pulmonary hypertension: feasibility and long-term outcome","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Physiol"},{"key":"2026012113160862700_ehf214659-bib-0015","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/europace\/euaa300","article-title":"Significance of post-pacing intervals shorter than tachycardia cycle length for successful catheter ablation of atypical flutter","volume":"23","author":"Dall'Aglio","year":"2021","journal-title":"Europace"},{"key":"2026012113160862700_ehf214659-bib-0016","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10840-021-00988-y","article-title":"Management of arrhythmias in pulmonary hypertension","volume":"62","author":"Reddy","year":"2021","journal-title":"J Interv Card Electrophysiol"},{"key":"2026012113160862700_ehf214659-bib-0017","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.ijcard.2012.06.024","article-title":"Atrial flutter and fibrillation in patients with pulmonary hypertension","volume":"167","author":"Olsson","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026012113160862700_ehf214659-bib-0018","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ahj.2006.09.008","article-title":"Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension","volume":"153","author":"Tongers","year":"2007","journal-title":"Am Heart J"},{"key":"2026012113160862700_ehf214659-bib-0019","doi-asserted-by":"publisher","DOI":"10.1177\/2045894018790316","article-title":"Atrial arrhythmias are associated with increased mortality in pulmonary arterial hypertension","volume":"8","author":"Smith","year":"2018","journal-title":"Pulm Circ"},{"key":"2026012113160862700_ehf214659-bib-0020","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1016\/j.jacep.2018.04.008","article-title":"The current landscape of atrial fibrillation and atrial flutter clinical trials: a report of 348 studies registered with ClinicalTrials.gov","volume":"4","author":"Patel","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2026012113160862700_ehf214659-bib-0021","doi-asserted-by":"publisher","DOI":"10.1177\/2045894018769874","article-title":"Pulmonary arterial hypertension and atrial arrhythmias: incidence, risk factors, and clinical impact","volume":"8","author":"Mercurio","year":"2018","journal-title":"Pulm Circ"},{"key":"2026012113160862700_ehf214659-bib-0022","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.cjco.2021.02.010","article-title":"Better outcomes in pulmonary arterial hypertension after repair of congenital heart disease, compared with idiopathic pulmonary arterial hypertension","volume":"3","author":"Xu","year":"2021","journal-title":"CJC Open"},{"key":"2026012113160862700_ehf214659-bib-0023","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1161\/CIRCULATIONAHA.110.969584","article-title":"Pediatric pulmonary hypertension in the Netherlands: Epidemiology and characterization during the period 1991 to 2005","volume":"124","author":"van Loon","year":"2011","journal-title":"Circulation"},{"key":"2026012113160862700_ehf214659-bib-0024","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.amjcard.2013.09.032","article-title":"Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL registry)","volume":"113","author":"Barst","year":"2014","journal-title":"Am J Cardiol"},{"key":"2026012113160862700_ehf214659-bib-0025","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S2213-2600(15)00543-3","article-title":"A global view of pulmonary hypertension","volume":"4","author":"Hoeper","year":"2016","journal-title":"Lancet Respir Med"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/2\/883\/64540259\/eschf_11_2_883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/11\/2\/883\/64540259\/eschf_11_2_883.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:18:07Z","timestamp":1769019487000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/11\/2\/883\/8271366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1,10]]},"published-print":{"date-parts":[[2024,4,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.14659","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,4]]},"published":{"date-parts":[[2024,1,10]]},"assertion":[{"value":"2023-07-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-18","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}